T Weiser
Overview
Explore the profile of T Weiser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carter-Pokras O, Hutchins S, Gaudino J, Veeranki S, Lurie P, Weiser T, et al.
Ann Epidemiol
. 2020 Oct;
62:100-114.
PMID: 33065268
One of the ten greatest public health achievements is childhood vaccination because of its impact on controlling and eliminating vaccine-preventable diseases (VPDs). Evidence-based immunization policies and practices are responsible for...
2.
Weiser T, Bacon A, Corum B, Van Lew H, Groom A
Vaccine
. 2018 Jul;
36(32 Pt B):4952-4957.
PMID: 30037485
Background: Government agencies, healthcare accreditation bodies and quality improvement organizations support the development of new quality measures. Composite quality measures use more than one measure to develop a broader assessment...
3.
Weiser T, Richter E, Hegewisch A, Muse D, Lange R
Eur J Pain
. 2017 Aug;
22(1):28-38.
PMID: 28805281
Background: Ibuprofen is an effective analgesic treatment with a ceiling effect at doses above 400 mg. This study compared the combination of ibuprofen 400 mg and caffeine 100 mg with...
4.
Kern K, Weiser T
Schmerz
. 2015 Nov;
29(6):632-40.
PMID: 26597641
Background: Neuropathic pain is difficult to treat and available options are frequently not sufficient. The expectorant ambroxol also works as a strong local anesthetic and blocks sodium channels about 40...
5.
Kern K, Weiser T
Schmerz
. 2015 Nov;
29 Suppl 3:S89-96.
PMID: 26589711
Background: Neuropathic pain is difficult to treat, and the available options are often inadequate. The expectorant ambroxol also acts as a strong local anaesthetic and blocks sodium channels about 40...
6.
Gaubitz M, Schiffer T, Holm C, Richter E, Pisternick-Ruf W, Weiser T
Eur J Pain
. 2015 May;
20(2):263-73.
PMID: 25929250
Background: Until now, nonivamide/nicoboxil ointment has not been tested in a randomized trial for the treatment of acute non-specific low back pain. Methods: This phase III randomized, double-blind, active- and...
7.
Weiser T, Blum W, Bentrup F
Planta
. 2013 Nov;
185(3):440-2.
PMID: 24186430
The patch-clamp technique was applied to vacuoles isolated from a photoautotrophic suspension cell culture of Chenopodium rubrum L. and vacuolar clamp currents, which are predominantly carried by the previously identified...
8.
Krueger D, Michel K, Allam S, Weiser T, Demir I, Ceyhan G, et al.
Neurogastroenterol Motil
. 2013 May;
25(8):e530-9.
PMID: 23682729
Background: Hyoscine butylbromide (HBB, Buscopan(®) ) is clinically used to treat intestinal cramps and visceral pain. Various studies, mainly on animal tissues, suggested that its antimuscarinic action is responsible for...
9.
Kustermann S, Boess F, Buness A, Schmitz M, Watzele M, Weiser T, et al.
Toxicol In Vitro
. 2012 Sep;
27(5):1589-95.
PMID: 22954529
Cell-based assays are key tools in drug safety assessment. However, they usually provide only limited information about time-kinetics of a toxic effect and implementing multiple measurements is often complex. To...
10.
Chrubasik S, Weiser T, Beime B
Phytother Res
. 2010 Nov;
24(12):1877-85.
PMID: 21104944
Topical capsaicin is an established treatment option for various pain conditions. In a randomized double-blind multi-centre study, 281 patients suffering from chronic soft tissue pain were treated either with a...